Rizatriptan Benzoate
NDC 65862-625, Rizatriptan Benzoate, tablet, orally disintegrating, from Aurobindo Pharma Limited.
- Product NDC
- 65862-625
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203062
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65862-625 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIZATRIPTAN BENZOATE5 mg/1
Pharmacologic classes
Serotonin 1b Receptor Agonists [MoA]; Serotonin 1d Receptor Agonists [MoA]; Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65862-625-12 | 65862062512 | 4 BLISTER PACK in 1 CARTON (65862-625-12) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (65862-625-03) |
| 65862-625-18 | 65862062518 | 3 BLISTER PACK in 1 CARTON (65862-625-18) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (65862-625-06) |
| 65862-625-36 | 65862062536 | 9 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-625-36) |
| 65862-625-48 | 65862062548 | 18 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-625-48) |
| 65862-625-64 | 65862062564 | 1 BLISTER PACK in 1 CARTON (65862-625-64) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (65862-625-03) |
| 65862-625-90 | 65862062590 | 3 BLISTER PACK in 1 CARTON (65862-625-90) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (65862-625-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a8e37688-426c-4290-933d-54a34ae86000NADAC price for package 65862062512
GET /v1/drugs/nadac/65862062512NADAC price for package 65862062590
GET /v1/drugs/nadac/65862062590
Use it
Look up 65862-625 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65862-625 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65862-625. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.